Overview

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
To determine the safety of sirolimus tablets in renal allograft recipients in a postmarketing surveillance setting.
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Everolimus
Sirolimus